Viola 2016 JACC: Basic to Translational Science: Difference between revisions
(Created page with "{{Publication |title=Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC (2016) The role of the L-type Ca2+...") |
No edit summary |
||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC (2016) The role of the L-type Ca2+ channel in altered metabolic activity in a murine model of hypertrophic cardiomyopathy. JACC: Basic to Translational Science 1: 61–72. | |title=Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC (2016) The role of the L-type Ca2+ channel in altered metabolic activity in a murine model of hypertrophic cardiomyopathy. JACC: Basic to Translational Science 1: 61–72. | ||
|info=[http://www.sciencedirect.com/science/article/pii/S2452302X16000115] | |info=[http://www.sciencedirect.com/science/article/pii/S2452302X16000115] | ||
|authors=Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC | |authors=Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC | ||
Line 17: | Line 17: | ||
Heterozygous mice (αMHC<sup>403/+</sup>) expressing the human disease-causing mutation ''Arg403Gln'' exhibit cardinal features of hypertrophic cardiomyopathy (HCM) including hypertrophy, myocyte disarray, and increased myocardial fibrosis. Treatment of αMHC<sup>403/+</sup> mice with the L-type calcium channel (I<sub>Ca-L</sub>) antagonist diltiazem has been shown to decrease left ventricular anterior wall thickness, cardiac myocyte hypertrophy, disarray, and fibrosis. However, the role of the I<sub>Ca-L</sub> in the development of HCM is not known. In addition to maintaining cardiac excitation and contraction in myocytes, the I<sub>Ca-L</sub> also regulates mitochondrial function through transmission of movement of I<sub>Ca-L</sub> via cytoskeletal proteins to mitochondrial voltage-dependent anion channel. Here, the authors investigated the role of I<sub>Ca-L</sub> in regulating mitochondrial function in αMHC<sup>403/+</sup> mice. Whole-cell patch clamp studies showed that I<sub>Ca-L</sub> current inactivation kinetics were significantly increased in αMHC<sup>403/+</sup> cardiac myocytes, but that current density and channel expression were similar to wild-type cardiac myocytes. Activation of I<sub>Ca-L</sub> caused a significantly greater increase in mitochondrial membrane potential and metabolic activity in αMHC<sup>403/+</sup>. These increases were attenuated with I<sub>Ca-L</sub> antagonists and following F-actin or β-tubulin depolymerization. The authors observed increased levels of fibroblast growth factor-21 in αMHC<sup>403/+</sup> mice, and altered mitochondrial DNA copy number consistent with altered mitochondrial activity and the development of cardiomyopathy. These studies suggest that the ''Arg403Gln'' mutation leads to altered functional communication between I<sub>Ca-L</sub> and mitochondria that is associated with increased metabolic activity, which may contribute to the development of cardiomyopathy. I<sub>Ca-L</sub> antagonists may be effective in reducing the cardiomyopathy in HCM by altering metabolic activity. | Heterozygous mice (αMHC<sup>403/+</sup>) expressing the human disease-causing mutation ''Arg403Gln'' exhibit cardinal features of hypertrophic cardiomyopathy (HCM) including hypertrophy, myocyte disarray, and increased myocardial fibrosis. Treatment of αMHC<sup>403/+</sup> mice with the L-type calcium channel (I<sub>Ca-L</sub>) antagonist diltiazem has been shown to decrease left ventricular anterior wall thickness, cardiac myocyte hypertrophy, disarray, and fibrosis. However, the role of the I<sub>Ca-L</sub> in the development of HCM is not known. In addition to maintaining cardiac excitation and contraction in myocytes, the I<sub>Ca-L</sub> also regulates mitochondrial function through transmission of movement of I<sub>Ca-L</sub> via cytoskeletal proteins to mitochondrial voltage-dependent anion channel. Here, the authors investigated the role of I<sub>Ca-L</sub> in regulating mitochondrial function in αMHC<sup>403/+</sup> mice. Whole-cell patch clamp studies showed that I<sub>Ca-L</sub> current inactivation kinetics were significantly increased in αMHC<sup>403/+</sup> cardiac myocytes, but that current density and channel expression were similar to wild-type cardiac myocytes. Activation of I<sub>Ca-L</sub> caused a significantly greater increase in mitochondrial membrane potential and metabolic activity in αMHC<sup>403/+</sup>. These increases were attenuated with I<sub>Ca-L</sub> antagonists and following F-actin or β-tubulin depolymerization. The authors observed increased levels of fibroblast growth factor-21 in αMHC<sup>403/+</sup> mice, and altered mitochondrial DNA copy number consistent with altered mitochondrial activity and the development of cardiomyopathy. These studies suggest that the ''Arg403Gln'' mutation leads to altered functional communication between I<sub>Ca-L</sub> and mitochondria that is associated with increased metabolic activity, which may contribute to the development of cardiomyopathy. I<sub>Ca-L</sub> antagonists may be effective in reducing the cardiomyopathy in HCM by altering metabolic activity. | ||
|keywords=Calcium, Cardiomyopathy, L-type calcium channel, Mitochondria | |keywords=Calcium, Cardiomyopathy, L-type calcium channel, Mitochondria | ||
|mipnetlab=AU Perth Filipovska A | |||
}} | }} | ||
{{Labeling | {{Labeling |
Revision as of 15:34, 6 May 2016
Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC (2016) The role of the L-type Ca2+ channel in altered metabolic activity in a murine model of hypertrophic cardiomyopathy. JACC: Basic to Translational Science 1: 61–72. |
» [1]
Viola HM, Johnstone VPA, Szappanos HC, Richman TR, Tsoutsman T, Filipovska A, Semsarian C, Seidman JG, Seidman CE, Hool LC (2016) JACC: Basic to Translational Science
Abstract: Highlights
Heterozygous mice (αMHC403/+) expressing the human hypertrophic cardiomyopathy (HCM) disease causing mutation Arg403Gln exhibit cardinal features of HCM. This study investigated the role of L-type Ca2+ channel (ICa-L) in regulating mitochondrial function in Arg403Gln (αMHC403/+) mice. Activation of ICa-L in αMHC403/+ mice caused a significantly greater increase in mitochondrial membrane potential and metabolic activity when compared to wild-type mice. Increases in mitochondrial membrane potential and metabolic activity were attenuated with ICa-L antagonists and when F-actin or β-tubulin were depolymerized. ICa-L antagonists may be effective in reducing the cardiomyopathy in HCM by altering metabolic activity.
Summary
Heterozygous mice (αMHC403/+) expressing the human disease-causing mutation Arg403Gln exhibit cardinal features of hypertrophic cardiomyopathy (HCM) including hypertrophy, myocyte disarray, and increased myocardial fibrosis. Treatment of αMHC403/+ mice with the L-type calcium channel (ICa-L) antagonist diltiazem has been shown to decrease left ventricular anterior wall thickness, cardiac myocyte hypertrophy, disarray, and fibrosis. However, the role of the ICa-L in the development of HCM is not known. In addition to maintaining cardiac excitation and contraction in myocytes, the ICa-L also regulates mitochondrial function through transmission of movement of ICa-L via cytoskeletal proteins to mitochondrial voltage-dependent anion channel. Here, the authors investigated the role of ICa-L in regulating mitochondrial function in αMHC403/+ mice. Whole-cell patch clamp studies showed that ICa-L current inactivation kinetics were significantly increased in αMHC403/+ cardiac myocytes, but that current density and channel expression were similar to wild-type cardiac myocytes. Activation of ICa-L caused a significantly greater increase in mitochondrial membrane potential and metabolic activity in αMHC403/+. These increases were attenuated with ICa-L antagonists and following F-actin or β-tubulin depolymerization. The authors observed increased levels of fibroblast growth factor-21 in αMHC403/+ mice, and altered mitochondrial DNA copy number consistent with altered mitochondrial activity and the development of cardiomyopathy. These studies suggest that the Arg403Gln mutation leads to altered functional communication between ICa-L and mitochondria that is associated with increased metabolic activity, which may contribute to the development of cardiomyopathy. ICa-L antagonists may be effective in reducing the cardiomyopathy in HCM by altering metabolic activity. • Keywords: Calcium, Cardiomyopathy, L-type calcium channel, Mitochondria
• O2k-Network Lab: AU Perth Filipovska A
Labels: MiParea: Respiration
Pathology: Myopathy
Organism: Mouse Tissue;cell: Heart Preparation: Isolated mitochondria
HRR: Oxygraph-2k
Labels, 2016-05